A phospholipid spin label used as a liposome-associated MRI contrast agent
- 1 October 1987
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 5 (4) , 371-376
- https://doi.org/10.1002/mrm.1910050409
Abstract
Given current clinical use of phospholipid bilayer structures (liposomes/vesicles) as non-toxic drug delivery vehicles, we have addressed the possibility of employing the phospholipids themselves as MRI contrast agents. To this end we have synthesized phosphatidylcholine with a nitroxide spin label replacing one methyl residue of the choline headgroup. This material was mixed with natural phosphatidylcholine in mole ratios from 150 to 1:1 and used to prepare sonicated unilamellar vesicles in saline. Expected structural features of these vesicles were verified by freeze-fracture electron microscopy. Proton T1 values of saline were readily decreased to less than 0.3 s by such preparations, yielding a net relaxivity of 0.6 M−1 s−1. The approach seems to be a realistic way of firmly associating a contrast agent of minimal toxicity with ordinary liposomes/vesicles in a manner that is not subject to leakage. © 1987 Academic Press, Inc.This publication has 6 references indexed in Scilit:
- Liposomes as drug carriers in cancer chemotherapyPharmacology & Therapeutics, 1984
- Relaxation enhancement using liposomes carrying paramagnetic speciesMagnetic Resonance Imaging, 1984
- Carrier Activity of Sonicated Small Liposomes Containing Melphalan to Regional Lymph Nodes of RatsPharmacology, 1983
- Targeting of lipid vesicles: specificity of carbohydrate receptor analogues for leukocytes in mice.Proceedings of the National Academy of Sciences, 1980
- Variations of size and distribution in suspensions of sonicated phospholipid bilayersBiochemical and Biophysical Research Communications, 1975
- Inside-outside transitions of phospholipids in vesicle membranesBiochemistry, 1971